Copyright
©The Author(s) 2019.
World J Gastroenterol. Oct 14, 2019; 25(38): 5883-5896
Published online Oct 14, 2019. doi: 10.3748/wjg.v25.i38.5883
Published online Oct 14, 2019. doi: 10.3748/wjg.v25.i38.5883
Figure 2 Analysis of basal core promoter /precore/core mutants related with the e-antigen negative status.
A: Prevalence of individual mutations of the in the 3 most frequent HBV genotypes analyzed; B: Frequency of coexistence of more than one BCP/precore/core mutants; and C: Frequency of the most common combination of mutations in the different genotypes. The frequency calculation was performed including only the 23 patients with precore/core sequences data, not in on intention to treat basis. BCP: Basal core promoter; HBV: Hepatitis B virus; A: HBV-A; D: HBV-D; E: HBV-E.
- Citation: Gil-García AI, Madejón A, Francisco-Recuero I, López-López A, Villafranca E, Romero M, García A, Olveira A, Mena R, Larrubia JR, García-Samaniego J. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment. World J Gastroenterol 2019; 25(38): 5883-5896
- URL: https://www.wjgnet.com/1007-9327/full/v25/i38/5883.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i38.5883